| Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3, 4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor L Ramos, C Hicks, R Kevin, A Caminer, R Narlawar, M Kassiou, ... Neuropsychopharmacology 38 (11), 2249-2259, 2013 | 137 | 2013 |
| Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non‐peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study … C Hicks, L Ramos, T Reekie, GH Misagh, R Narlawar, M Kassiou, ... British journal of pharmacology 171 (11), 2868-2887, 2014 | 86 | 2014 |
| The nonpeptide oxytocin receptor agonist WAY 267,464: Receptor‐binding profile, prosocial effects and distribution of c‐Fos expression in adolescent rats C Hicks, W Jorgensen, C Brown, J Fardell, J Koehbach, CW Gruber, ... Journal of neuroendocrinology 24 (7), 1012-1029, 2012 | 82 | 2012 |
| Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion CP Motbey, E Karanges, KM Li, S Wilkinson, AR Winstock, J Ramsay, ... Public Library of Science 7 (9), e45473, 2012 | 64 | 2012 |
| Adolescent pre‐treatment with oxytocin protects against adult methamphetamine‐seeking behavior in female rats C Hicks, JL Cornish, SJ Baracz, A Suraev, IS McGregor Addiction biology 21 (2), 304-315, 2016 | 56 | 2016 |
| DARK classics in chemical neuroscience: cathinone-derived psychostimulants SJ Simmons, JM Leyrer-Jackson, CF Oliver, C Hicks, JW Muschamp, ... ACS chemical neuroscience 9 (10), 2379-2394, 2018 | 50 | 2018 |
| Oxytocin and MDMA (‘Ecstasy’) enhance social reward in rats L Ramos, C Hicks, A Caminer, J Goodwin, IS McGregor Psychopharmacology 232, 2631-2641, 2015 | 44 | 2015 |
| Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator RA Gregg, C Hicks, SU Nayak, CS Tallarida, P Nucero, GR Smith, ... Neuropharmacology 108, 111-119, 2016 | 43 | 2016 |
| Adolescent exposure to oxytocin, but not the selective oxytocin receptor agonist TGOT, increases social behavior and plasma oxytocin in adulthood AS Suraev, MT Bowen, SO Ali, C Hicks, L Ramos, IS McGregor Hormones and behavior 65 (5), 488-496, 2014 | 43 | 2014 |
| Synthetic cathinones and stereochemistry: S enantiomer of mephedrone reduces anxiety-and depressant-like effects in cocaine-or MDPV-abstinent rats HL Philogene-Khalid, C Hicks, AB Reitz, LY Liu-Chen, SM Rawls Drug and alcohol dependence 178, 119-125, 2017 | 38 | 2017 |
| WAY 267,464, a non-peptide oxytocin receptor agonist, impairs social recognition memory in rats through a vasopressin 1A receptor antagonist action C Hicks, L Ramos, TA Reekie, R Narlawar, M Kassiou, IS McGregor Psychopharmacology 232, 2659-2667, 2015 | 24 | 2015 |
| Dopamine D1-like receptor agonist and D2-like receptor antagonist (−)-stepholidine reduces reinstatement of drug-seeking behavior for 3, 4-methylenedioxypyrovalerone (MDPV) in rats C Hicks, P Huang, L Ramos, SU Nayak, Y Caro, AB Reitz, GR Smith, ... ACS chemical neuroscience 9 (6), 1327-1337, 2018 | 23 | 2018 |
| MDMA (‘Ecstasy’), oxytocin and vasopressin modulate social preference in rats: A role for handling and oxytocin receptors L Ramos, C Hicks, A Caminer, K Couto, R Narlawar, M Kassiou, ... Pharmacology Biochemistry and Behavior 150, 115-123, 2016 | 22 | 2016 |
| Regional c-Fos expression induced by peripheral oxytocin administration is prevented by the vasopressin 1A receptor antagonist SR49059 C Hicks, L Ramos, B Dampney, SJ Baracz, IS McGregor, GE Hunt Brain Research Bulletin 127, 208-218, 2016 | 22 | 2016 |
| Inhaled vasopressin increases sociability and reduces body temperature and heart rate in rats L Ramos, C Hicks, A Caminer, IS McGregor Psychoneuroendocrinology 46, 46-51, 2014 | 22 | 2014 |
| Glutamate carboxypeptidase II (GCPII) inhibitor 2-PMPA reduces rewarding effects of the synthetic cathinone MDPV in rats: a role for N-acetylaspartylglutamate … C Hicks, RA Gregg, SU Nayak, LA Cannella, GJ Schena, CS Tallarida, ... Psychopharmacology 234, 1671-1681, 2017 | 20 | 2017 |
| Sigma receptors and substance use disorders V Sabino, C Hicks, P Cottone Sigma Receptors: Their Role in Disease and as Therapeutic Targets, 177-199, 2017 | 18 | 2017 |
| The alpha-1 adrenergic receptor antagonist prazosin reduces binge-like eating in rats C Hicks, V Sabino, P Cottone Nutrients 12 (6), 1569, 2020 | 11 | 2020 |
| Fasting and exercise increase plasma cannabinoid levels in THC pre-treated rats: an examination of behavioural consequences A Wong, K Keats, K Rooney, C Hicks, DJ Allsop, JC Arnold, IS McGregor Psychopharmacology 231, 3987-3996, 2014 | 10 | 2014 |
| Therapeutic compounds and compositions for treating social disorders and substance use disorders IS McGregor, M Kassiou, MT Bowen, C Hicks, W Jorgensen US Patent 11,890,287, 2024 | | 2024 |
Iain S. McGregorUniversity of SydneyVerified email at sydney.edu.au
